BioCorRx Inc. (OTCMKTS:BICX) Short Interest Up 23.9% in March

BioCorRx Inc. (OTCMKTS:BICX) was the recipient of a large increase in short interest in March. As of March 31st, there was short interest totalling 8,800 shares, an increase of 23.9% from the March 15th total of 7,100 shares. Based on an average daily volume of 7,100 shares, the days-to-cover ratio is currently 1.2 days. Approximately 0.1% of the shares of the company are short sold.

BioCorRx Price Performance

OTCMKTS BICX opened at $0.49 on Monday. BioCorRx has a 52 week low of $0.26 and a 52 week high of $1.50. The firm has a market cap of $8.28 million, a PE ratio of -0.94 and a beta of 0.06. The business’s fifty day simple moving average is $0.38 and its 200-day simple moving average is $0.38.

BioCorRx (OTCMKTS:BICX) last posted its earnings results on Monday, March 31st. The company reported ($0.08) earnings per share (EPS) for the quarter.

About BioCorRx

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.